Cardlytics Inc expected to post a loss of 1 cent a share - Earnings Preview

Cardlytics

27/10/2023 12:08

* Cardlytics Inc  CDLX.OQ   CDLX.O  is expected to show a
rise in
quarterly revenue when it reports  results 
    * The Atlanta Georgia-based  company is expected to report 
a
10.0% increase in revenue to $80.011 million from $72.71 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. The company's guidance on August 1
2023, for the period ended September 30, was for revenue between
$75.00 million and $84.00 million.
    * ​Refinitiv's mean analyst estimate for Cardlytics Inc is
for a
loss of 1 cent per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cardlytics
Inc is
$17​, above​ its last closing price of $11.74. ​​​

The company's guidance on August 1 2023 for the period ended
September 30 was for Earnings before Interest, Taxes,
Depreciation and Amortization of between 75 million and 2
million (USD).
This summary was machine generated October 27 at 11:08 GMT.  All
figures in US dollars  unless otherwise stated